Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-057382

Chief Scientific Officer sold 33,300 shares at an average $50.70 ($1,688,247)

  • Chief Scientific Officer acquired 33,300 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

ROBINS HARLAN S · Chief Scientific Officer

Table I: Non-derivative

10 lines
Date Transaction Shares Price Value Owned after D/I
2020-11-04 Exercise or conversion : show line 1 in the form +11,100 $6.32 $70,152 11,779 D
2020-11-04 Sale : show line 2 in the form −9,800 $50.20 $491,960 1,979 D
2020-11-04 Sale : show line 3 in the form −1,300 $50.98 $66,274 679 D
2020-11-05 Exercise or conversion : show line 4 in the form +11,100 $6.32 $70,152 11,779 D
2020-11-05 Sale : show line 5 in the form −7,254 $50.00 $362,700 4,525 D
2020-11-05 Sale : show line 6 in the form −3,846 $50.88 $195,684 679 D
2020-11-06 Exercise or conversion : show line 7 in the form +11,100 $6.32 $70,152 11,779 D
2020-11-06 Sale : show line 8 in the form −1,500 $50.48 $75,720 10,279 D
2020-11-06 Sale : show line 9 in the form −8,700 $51.57 $448,659 1,579 D
2020-11-06 Sale : show line 10 in the form −900 $52.50 $47,250 679 D
Open-market sales · 33,300 sh · avg $50.70 · $1,688,247

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2020-11-04 Exercise or conversion : show line 11 in the form Stock Option (Right to Buy) −11,100 255,900 D
2020-11-05 Exercise or conversion : show line 12 in the form Stock Option (Right to Buy) −11,100 244,800 D
2020-11-06 Exercise or conversion : show line 13 in the form Stock Option (Right to Buy) −11,100 233,700 D
Loading xslF345X03/doc4.xml…